Aprea Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Aprea Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aprea Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aprea Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $107k | 63k | 1.69 |
| 2024-12-31 | $121k | 37k | 3.29 |
| 2024-09-30 | $94k | 34k | 2.75 |
| 2024-06-30 | $122k | 30k | 4.08 |
| 2024-03-31 | $179k | 27k | 6.69 |
| 2023-12-31 | $81k | 17k | 4.70 |
| 2023-09-30 | $61k | 15k | 4.17 |
| 2023-06-30 | $48k | 15k | 3.15 |